Literature DB >> 26451051

Pharmacist review and its impact on Singapore nursing homes.

Hui Shan Chia1, John Aik Hui Ho2, Bernadette Daolin Lim3.   

Abstract

INTRODUCTION: There is a high prevalence of polypharmacy and inappropriate medication use in Singapore nursing homes. This study primarily explored the benefits of pharmacist reviews in local nursing homes. The secondary aims were to review the potential cost savings gained from following the pharmacists' recommendations and to identify the possible risks associated with polypharmacy and inappropriate medication use.
METHODS: A retrospective period prevalence study was performed. We analysed the pharmacotherapy problems highlighted by pharmacists in three nursing homes and the rate of acceptance of pharmacists' recommendations. Data was collected in two phases: (a) a one-month pre-setup period, during which 480 patients were reviewed (i.e. one-time review before weekly pharmacist visits); and (b) a six-month post-setup period, during which the 480 patients were reviewed again. Pharmacotherapy problems were classified according to a clinical pharmacist recommendation taxonomy and potential risks were identified. Monthly cost savings were calculated and compared with the monthly costs of pharmacist reviews.
RESULTS: A total of 392 pharmacotherapy problems were identified, with pharmacist recommendations noted for each problem. Among the 392 recommendations, 236 (60.2%) were accepted. The pharmacotherapy problems were analysed for potential risks, including falls (16.0%) and constipation (13.1%). The acceptance rates were higher during the post-setup period compared to the pre-setup period (p < 0.0001). Total direct acquisition cost savings during the pre- and post-setup periods were SGD 388.30 and SGD 876.69, respectively.
CONCLUSION: The provision of pharmaceutical care to nursing home residents resulted in improved medication safety and quality of care.

Entities:  

Keywords:  Singapore; nursing homes; pharmacists

Mesh:

Year:  2015        PMID: 26451051      PMCID: PMC4582128          DOI: 10.11622/smedj.2015133

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  21 in total

Review 1.  The role of patient care teams in chronic disease management.

Authors:  E H Wagner
Journal:  BMJ       Date:  2000-02-26

Review 2.  Outcomes of polypharmacy in nursing home residents.

Authors:  Bruce K Tamura; Christina L Bell; Michiko Inaba; Kamal H Masaki
Journal:  Clin Geriatr Med       Date:  2012-02-23       Impact factor: 3.076

Review 3.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

4.  Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study.

Authors:  Matteo Tosato; Francesco Landi; Anna Maria Martone; Antonio Cherubini; Andrea Corsonello; Stefano Volpato; Roberto Bernabei; Graziano Onder
Journal:  Age Ageing       Date:  2014-03-17       Impact factor: 10.668

5.  A qualitative study of physicians' and nurses' experiences of multidisciplinary collaboration with pharmacists participating at case conferences.

Authors:  Kjell H Halvorsen; Per Stensland; Anne Gerd Granas
Journal:  Int J Pharm Pract       Date:  2011-06-09

6.  General practitioners' perceptions of pharmacists' new services in New Zealand.

Authors:  Ernieda Hatah; Rhiannon Braund; Stephen Duffull; June Tordoff
Journal:  Int J Clin Pharm       Date:  2012-02-23

7.  Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration.

Authors:  Fay Bradley; Darren M Ashcroft; Peter R Noyce
Journal:  Res Social Adm Pharm       Date:  2011-03-31

Review 8.  Guidance on the management of pain in older people.

Authors:  Aza Abdulla; Nicola Adams; Margaret Bone; Alison M Elliott; Jean Gaffin; Derek Jones; Roger Knaggs; Denis Martin; Liz Sampson; Pat Schofield
Journal:  Age Ageing       Date:  2013-03       Impact factor: 10.668

9.  Pharmacists' performance of clinical interventions during adherence support medication reviews.

Authors:  Ernieda Hatah; June Tordoff; Stephen B Duffull; Rhiannon Braund
Journal:  Res Social Adm Pharm       Date:  2013-05-17

10.  Potentially inappropriate medications used by the elderly: prevalence and risk factors in Brazilian care homes.

Authors:  Thaís Jaqueline Vieira de Lima; Cléa Adas Saliba Garbin; Artênio José Isper Garbin; Dóris Hissako Sumida; Orlando Saliba
Journal:  BMC Geriatr       Date:  2013-05-30       Impact factor: 3.921

View more
  5 in total

Review 1.  Pharmacist services in nursing homes: A systematic review and meta-analysis.

Authors:  Shaun Wen Huey Lee; Vivienne Sook Li Mak; Yee Woon Tang
Journal:  Br J Clin Pharmacol       Date:  2019-11-03       Impact factor: 4.335

2.  The social transformation of Singapore medicine through 55 years of the SMJ.

Authors:  Ee Heok Kua; Jade Phek Hui Kua
Journal:  Singapore Med J       Date:  2016-11       Impact factor: 1.858

3.  Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia.

Authors:  Li Min Lim; Megan McStea; Wen Wei Chung; Nuruljannah Nor Azmi; Siti Azdiah Abdul Aziz; Syireen Alwi; Adeeba Kamarulzaman; Shahrul Bahyah Kamaruzzaman; Siew Siang Chua; Reena Rajasuriar
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

4.  Economic Impact of Pharmacist-Participated Medication Management for Elderly Patients in Nursing Homes: A Systematic Review.

Authors:  Arim Kwak; Yoo Jin Moon; Yun-Kyoung Song; Hwi-Yeol Yun; Kyungim Kim
Journal:  Int J Environ Res Public Health       Date:  2019-08-16       Impact factor: 3.390

5.  Perspectives of Non-Pharmacy Professionals in Long-Term Care Facilities on Pharmacist-Involved Medication Management in South Korea: A Qualitative Study.

Authors:  Arim Kwak; Euni Lee; Jung Mi Oh; Eunhee Ji; Kyungim Kim
Journal:  Int J Environ Res Public Health       Date:  2019-06-04       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.